Stockreport

Acorda Therapeutics Announces Agreement for Sale of Manufacturing Operations and Long-Term Global Supply Agreement for INBRIJA®, Corporate Restructuring, and Enters into “At The Market” Of...

Acorda Therapeutics, Inc.  (ACOR) 
Last acorda therapeutics, inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors
PDF $80 million up-front payment will substantially increase cash balanceSale, restructuring and other operating expense reductions will reduce annual operating expenses by [Read more]